Amedeo Smart

Free Medical Literature Service



HIV Infection

  Free Subscription

Articles published in
J Med Virol
    July 2018
  1. JOGEDA EL, Avi R, Pauskar M, Kallas E, et al
    Association of IFNlambda4 rs12979860 Polymorphism with the Acquisition of HCV and HIV Infections among People Who Inject Drugs.
    J Med Virol. 2018 Jul 10. doi: 10.1002/jmv.25258.
    >> Share

  2. SONG JE, Ahn MY, Kim WJ, Kim SW, et al
    Prevalence of CCR5 tropism among HIV-1-infected patients in South Korea.
    J Med Virol. 2018 Jul 7. doi: 10.1002/jmv.25254.
    >> Share

    June 2018
  3. DEGEFA B, Gebreeyesus T, Gebremedhin Z, Melkamu G, et al
    Prevalence of hepatitis B virus, hepatitis C virus and human immunodeficiency virus among blood donors of Mekelle blood bank, Northern Ethiopia: A three year retrospective study.
    J Med Virol. 2018 Jun 15. doi: 10.1002/jmv.25248.
    >> Share

  4. KARKASHADZE E, Dvali N, Bolokadze N, Sharvadze L, et al
    Epidemiology of HIV drug resistance in HIV patients with virologic failure of first-line therapy in the country of Georgia.
    J Med Virol. 2018 Jun 15. doi: 10.1002/jmv.25245.
    >> Share

    May 2018
  5. SMELOV V, Elfstrom KM, Eklund C, Sokolova O, et al
    Determinants of presence of human papillomaviruses in the anal canal of Russian men.
    J Med Virol. 2018 May 24. doi: 10.1002/jmv.25234.
    >> Share

  6. TAMALET C, Tissot-Dupont H, Motte A, Tourres C, et al
    Emergence of uncommon HIV-1 non-B subtypes and circulating recombinant forms and trends in transmission of antiretroviral drug resistance in patients with primary infection during the 2013-2015 period in Marseille, Southeastern France.
    J Med Virol. 2018 May 24. doi: 10.1002/jmv.25228.
    >> Share

  7. HILDENBRAND C, Wedekind L, Li G, vonRentzell JE, et al
    Clinical evaluation of Roche COBAS((R)) AmpliPrep/COBAS((R)) TaqMan((R)) CMV Test using non-plasma samples.
    J Med Virol. 2018 May 24. doi: 10.1002/jmv.25226.
    >> Share

  8. NICOT F, Jeanne N, Raymond S, Delfour O, et al
    Performance comparison of deep sequencing platforms for detecting HIV-1 variants in the pol gene.
    J Med Virol. 2018 May 11. doi: 10.1002/jmv.25224.
    >> Share

  9. DE DIEU LONGO J, Bouassa RM, Simaleko MM, Kouabosso A, et al
    Usefulness of simultaneous screening for HIV- and HCV- specific antibodies and HBsAg by capillary-based multiplex rapid diagnostic test to strengthen linkage-to-care in sub-Saharan patients attending sexually transmitted infections clinic.
    J Med Virol. 2018 May 2. doi: 10.1002/jmv.25209.
    >> Share

    April 2018
  10. KUAI Q, Lu X, Qiao Z, Wang R, et al
    Histone deacetylase inhibitor chidamide promotes reactivation of latent HIV by introducing histone acetylation.
    J Med Virol. 2018 Apr 28. doi: 10.1002/jmv.25207.
    >> Share

  11. PIRAYESHFARD L, Sharifi Z, Amini-Kafiabad S, Sadaghiani NH, et al
    Phylogenetic analysis of HTLV-1 in Iranian blood donors, HIV-1 positive patients and patients with beta thalassemia.
    J Med Virol. 2018 Apr 16. doi: 10.1002/jmv.25192.
    >> Share

  12. MOSITES E, Gounder P, Snowball M, Morris J, et al
    Hepatitis A vaccine immune response 22 years after vaccination.
    J Med Virol. 2018 Apr 16. doi: 10.1002/jmv.25197.
    >> Share

  13. MOSITES E, Gounder P, Snowball M, Morris J, et al
    Hepatitis A vaccine immune response 22 years after vaccination.
    J Med Virol. 2018 Apr 12. doi: 10.1002/jmv.25089.
    >> Share

    March 2018
  14. SINGH R, Mukherjee A, Singla M, Vajpayee M, et al
    Impact of HIV infection and highly active antiretroviral therapy (HAART) on B cell subpopulations in children.
    J Med Virol. 2018 Mar 25. doi: 10.1002/jmv.25074.
    >> Share

  15. CHEN ZW, Liu L, Chen G, Cheung KW, et al
    Surging HIV-1 CRF07_BC epidemic among recently infected men who have sex with men in Fujian, China.
    J Med Virol. 2018 Mar 25. doi: 10.1002/jmv.25072.
    >> Share

  16. DENG H, Deng X, Liu Y, Xu Y, et al
    Naturally occurring antiviral drug resistance in HIV patients who are mono-infected or co-infected with HBV or HCV in China.
    J Med Virol. 2018 Mar 24. doi: 10.1002/jmv.25078.
    >> Share

  17. GAO L, Wang Y, Li Y, Dong Y, et al
    Genome-wide expression profiling analysis to identify key genes in the anti-HIV mechanism of CD4(+) and CD8(+) T cells.
    J Med Virol. 2018 Mar 6. doi: 10.1002/jmv.25071.
    >> Share

    February 2018
  18. ZHOU S, Ren L, Xia X, Miao Z, et al
    Hepatitis E virus infection in HIV-infected patients: a large cohort study in Yunnan province, China.
    J Med Virol. 2018 Feb 19. doi: 10.1002/jmv.25060.
    >> Share

  19. GRECO L, Renteria SCU, Guarneri D, Orlandi A, et al
    HEV and HAV seroprevalence in men that have sex with men (MSM): an update from Milan, Italy.
    J Med Virol. 2018 Feb 15. doi: 10.1002/jmv.25052.
    >> Share

  20. MANCINELLI S, Pirillo MF, Liotta G, Andreotti M, et al
    J Med Virol. 2018 Feb 10. doi: 10.1002/jmv.25049.
    >> Share

  21. RAO D, Venkataswamy MM, Vasanthapuram R, Satishchandra P, et al
    Alterations in natural killer and dendritic cell subsets in individuals with HIV-associated neurotuberculosis.
    J Med Virol. 2018 Feb 3. doi: 10.1002/jmv.25042.
    >> Share

    January 2018
  22. MARIO S, Carmine M, Stefania P, Margherita M, et al
    J Med Virol. 2018 Jan 9. doi: 10.1002/jmv.25022.
    >> Share

    December 2017
  23. VERGARA-ORTEGA DN, Sevilla-Reyes EE, Herrera-Ortiz A, Torres-Ibarra L, et al
    J Med Virol. 2017 Dec 13. doi: 10.1002/jmv.25003.
    >> Share

    November 2017
  24. SU S, Fairley CK, Sasadeusz J, He J, et al
    HBV, HCV, and HBV/HCV co-infection among HIV-positive patients in Hunan province, China: regimen selection, hepatotoxicity, and antiretroviral therapy outcome.
    J Med Virol. 2017 Nov 1. doi: 10.1002/jmv.24988.
    >> Share

    October 2017
  25. CARRASCO I, Arias A, Benitez-Gutierrez L, Lledo G, et al
    Baseline NS5A Resistance Associated Substitutions May Impair DAA Response in Real-World Hepatitis C Patients.
    J Med Virol. 2017 Oct 9. doi: 10.1002/jmv.24971.
    >> Share

  26. LIU Z, Fang Q, Zuo J, Chen Y, et al
    Global Epidemiology of Human Herpesvirus 8 in Men Who Have Sex with Men: A Systematic Review and Meta-analysis.
    J Med Virol. 2017 Oct 3. doi: 10.1002/jmv.24960.
    >> Share

  27. AMPONSAH-DACOSTA E, Selabe SG, Mphahlele MJ
    Evolution of the serologic and virologic course of occult HBV infection in therapy experienced HIV co-infected patients.
    J Med Virol. 2017 Oct 2. doi: 10.1002/jmv.24956.
    >> Share

    September 2017
  28. RAHMAN M, Hossain ME, Afrad MH, Hasan R, et al
    Hepatitis C Virus infections among clients attending an HIV testing and counseling center in Dhaka, Bangladesh.
    J Med Virol. 2017 Sep 28. doi: 10.1002/jmv.24955.
    >> Share

  29. UCCIFERRI C, Tamburro M, Falasca K, Sammarco ML, et al
    Prevalence of anal, oral, penile and urethral Human Papillomavirus in HIV infected and HIV uninfected men who have sex with men.
    J Med Virol. 2017 Sep 14. doi: 10.1002/jmv.24943.
    >> Share

  30. CAVARETTO LDSP, Motta-Castro ARC, Teles SA, de Souza FQ, et al
    Epidemiological and molecular analysis of hepatitis B virus infection in manicurists in Central Brazil.
    J Med Virol. 2017 Sep 8. doi: 10.1002/jmv.24940.
    >> Share

    August 2017
  31. DEHGHANI-DEHEJ F, Sarvari J, Esghaei M, Hosseini SY, et al
    Presence of Different Hepatitis C Virus Genotypes in Plasma and Peripheral Blood Mononuclear Cell Samples of Iranian Patients with HIV Infection.
    J Med Virol. 2017 Aug 28. doi: 10.1002/jmv.24925.
    >> Share

  32. ZHAO C, Geng Y, Huang W, Ma H, et al
    Valuable Antibody Detection Method for Classifying Hepatitis E Virus Genotypes.
    J Med Virol. 2017 Aug 17. doi: 10.1002/jmv.24915.
    >> Share

  33. YANG T, Chen Q, Li D, Wang T, et al
    High prevalence of syphilis, HBV and HCV co-infection, and low rate of effective vaccination against hepatitis B in HIV-infected patients in West China hospital.
    J Med Virol. 2017 Aug 9. doi: 10.1002/jmv.24912.
    >> Share

  34. JOSE-ABREGO A, Panduro A, Fierro NA, Roman S, et al
    High prevalence of HBV infection, detection of subgenotypes F1b, A2 and D4 and differential risk factors among Mexican risk populations with low socioeconomic status.
    J Med Virol. 2017 Aug 9. doi: 10.1002/jmv.24913.
    >> Share

  35. MIRANDA AE, Silveira MF, Travassos AG, Tenorio T, et al
    High-risk Papillomavirus infection among Women living with Human Immunodeficiency Virus: Brazilian multicentric study.
    J Med Virol. 2017 Aug 3. doi: 10.1002/jmv.24906.
    >> Share

    July 2017
  36. WEHMEYER MH, Ingiliz P, Christensen S, Hueppe D, et al
    Real-world effectiveness of sofosbuvir-based treatment regimens for chronic hepatitis C genotype 3 infection: results from the multicenter German hepatitis C cohort (GECCO-03).
    J Med Virol. 2017 Jul 15. doi: 10.1002/jmv.24903.
    >> Share

  37. LISBOA NETO G, M Malta F, Gomes-Gouvea MS, F Noble C, et al
    J Med Virol. 2017 Jul 12. doi: 10.1002/jmv.24900.
    >> Share

  38. MARRA E, King A, van Logchem E, van der Weele P, et al
    Anal HPV 16 and 18 viral load: a comparison between HIV-negative and HIV-positive MSM and association with persistence.
    J Med Virol. 2017 Jul 12. doi: 10.1002/jmv.24898.
    >> Share

    June 2017
  39. GANTNER P, Melard A, Damond F, Delaugerre C, et al
    Interlaboratory quality control of total HIV-1 DNA load measurement for multicenter reservoir studies.
    J Med Virol. 2017 Jun 15. doi: 10.1002/jmv.24874.
    >> Share

  40. TRABAUD MA, Icard V, Ramiere C, Tardy JC, et al
    Comparison of HIV-1 drug-resistance genotyping by Ultra-Deep Sequencing and Sanger sequencing using clinical samples.
    J Med Virol. 2017 Jun 7. doi: 10.1002/jmv.24872.
    >> Share

    May 2017
  41. KUANG WD, Zhou YH, Zhong P, Zhang C, et al
    Amino Acids at Positions 3, 168 and 169 are Associated with the Ability of Nef Proteins from HIV-1 CRF01_AE to Downmodulate CD4.
    J Med Virol. 2017 May 13. doi: 10.1002/jmv.24851.
    >> Share

  42. LINS L, Farias E, Brites-Alves C, Torres A, et al
    Increased expression of CD38 and HLADR in HIV-infected patients with oral lesion.
    J Med Virol. 2017 May 13. doi: 10.1002/jmv.24852.
    >> Share

  43. DOS SANTOS MIMA, Rugiere SP, Stocker A, Schinoni MI, et al
    Mutations Associated With Drug Resistance and Prevalence of Vaccine Escape Mutations In Patients With Chronic Hepatitis B Infection.
    J Med Virol. 2017 May 13. doi: 10.1002/jmv.24853.
    >> Share

    April 2017
  44. BLACKARD JT, Ma G, Welge JA, Taylor LE, et al
    Cytokine/chemokine expression associated with Human Pegivirus (HPgV) infection in women with HIV.
    J Med Virol. 2017 Apr 29. doi: 10.1002/jmv.24836.
    >> Share

  45. JABLONOWSKA E, Pulik P, Kalinowska A, Gasiorowski J, et al
    "Efficacy and safety of nucleoside-sparing regimen based on raltegravir and ritonavir-boosted darunavir in HIV-1-infected treatment-experienced patients".
    J Med Virol. 2017 Apr 8. doi: 10.1002/jmv.24826.
    >> Share

  46. DUBE MANDISHORA RS, Christiansen IK, Chin'ombe N, Duri K, et al
    Genotypic diversity of anogenital human papillomavirus in women attending cervical cancer screening in Harare, Zimbabwe.
    J Med Virol. 2017 Apr 8. doi: 10.1002/jmv.24825.
    >> Share

    March 2017
  47. HUSAIN M, Sharma U, Gupta P, Singhal M, et al
    Comparative genetic variability in HIV-1 subtype C nef gene in early age groups of infants.
    J Med Virol. 2017 Mar 31. doi: 10.1002/jmv.24820.
    >> Share

  48. SNELL LB, Smith C, Chaytor S, McRae K, et al
    Screening for potential susceptibility to rubella in an antenatal population: A multivariate analysis.
    J Med Virol. 2017 Mar 31. doi: 10.1002/jmv.24818.
    >> Share

  49. COMAR M, Seraceni S, Colli C, Luska V, et al
    Chlamydia trachomatis and HPV co-infections in HIV negative men from a multi-ethnic area of Northern Italy at high prevalence of cervical malignancies.
    J Med Virol. 2017 Mar 18. doi: 10.1002/jmv.24811.
    >> Share

  50. LIU Z, Fang Q, Zhou S, Minhas V, et al
    Seroprevalence of Kaposi's sarcoma-associated herpesvirus among HIV-infected Uygurs in Xinjiang, China.
    J Med Virol. 2017 Mar 2. doi: 10.1002/jmv.24804.
    >> Share

    February 2017
  51. AUGUSTO A, Augusto O, Taquimo A, Nhachigule C, et al
    First description of HTLV-1/2 seroprevalence in HIV-infected inmates in Mozambique.
    J Med Virol. 2017 Feb 27. doi: 10.1002/jmv.24801.
    >> Share

  52. SAMLEERAT T, Hongjaisee S, Phiayura P, Sirirungsi W, et al
    HIV-1 coreceptor usage in perinatally infected Thai children.
    J Med Virol. 2017 Feb 15. doi: 10.1002/jmv.24790.
    >> Share

  53. ZHANG L, Wang B, Liang Y, Feng Y, et al
    Phylogenetic characteristics of HIV-1 among travelers entering China from Myanmar: A retrospective study.
    J Med Virol. 2017 Feb 15. doi: 10.1002/jmv.24786.
    >> Share

  54. FLORES GL, Cruz HM, Marques VA, Villela-Nogueira CA, et al
    Performance of anti-HCV testing in dried blood spots and saliva according to HIV status.
    J Med Virol. 2017 Feb 6. doi: 10.1002/jmv.24777.
    >> Share

    January 2017
  55. GRANDAL M, Pernas B, Marino A, Alvarez H, et al
    Characterization of chronic HCV infection in Northwest Spain: Impact of the treatment strategic plan of the Spanish National Health Service on HCV cure.
    J Med Virol. 2017 Jan 12. doi: 10.1002/jmv.24766.
    >> Share

    December 2016
  56. PAIVA A, Smid J, Haziot ME, Assone T, et al
    High risk of heterosexual transmission of human T-cell lymphotropic virus type 1 infection in Brazil.
    J Med Virol. 2016 Dec 9. doi: 10.1002/jmv.24745.
    >> Share

  57. KODANI M, Ahmed N, Tejada-Strop A, Poe A, et al
    Variability in the performance characteristics of IgG anti-HEV assays and its impact on reliability of seroprevalence rates of hepatitis E.
    J Med Virol. 2016 Dec 6. doi: 10.1002/jmv.24741.
    >> Share

  58. WANG B, Liang Y, Wang Y, Feng Y, et al
    HIV prevalence and phylogenetic characteristics among entry travelers in Xishuangbanna prefecture, Yunnan Province, between 2003 and 2012.
    J Med Virol. 2016 Dec 6. doi: 10.1002/jmv.24740.
    >> Share

    November 2016
  59. SHARMA AL, Singh TR, Devi KR, Singh LS, et al
    Molecular epidemiology of HIV-1 among the HIV infected people of Manipur, Northeastern India: Emergence of unique recombinant forms.
    J Med Virol. 2016 Nov 21. doi: 10.1002/jmv.24738.
    >> Share

  60. SALEMI JL, Spooner KK, Mejia de Grubb MC, Aggarwal A, et al
    National trends of hepatitis B and C during pregnancy across sociodemographic, behavioral, and clinical factors, United States, 1998-2011.
    J Med Virol. 2016 Nov 2. doi: 10.1002/jmv.24725.
    >> Share

    October 2016
  61. WANG N, Li Y, Han Y, Xie J, et al
    HIV sequence diversity during the early phase of infection is associated with HIV DNA reductions during antiretroviral therapy.
    J Med Virol. 2016 Oct 28. doi: 10.1002/jmv.24723.
    >> Share

  62. LIU Z, Fang Q, Zuo J, Wang J, et al
    High seroprevalence of human herpesvirus 8 and herpes simplex virus 2 infections in men who have sex with men in Shanghai, China.
    J Med Virol. 2016 Oct 21. doi: 10.1002/jmv.24718.
    >> Share

    September 2016
  63. JOGEDA EL, Huik K, Pauskar M, Kallas E, et al
    The prevalence and genotypes of GBV-C and its associations with HIV infection among persons who inject drugs in Eastern Europe.
    J Med Virol. 2016 Sep 7. doi: 10.1002/jmv.24683.
    >> Share

  64. SLAVOV SN, Otaguiri KK, Smid J, de Oliveira AC, et al
    Human parvovirus 4 prevalence among HTLV-1/2 infected individuals in Brazil.
    J Med Virol. 2016 Sep 2. doi: 10.1002/jmv.24673.
    >> Share

    August 2016
  65. WU S, Yan P, Yang T, Wang Z, et al
    Epidemiological profile and risk factors of HIV and HBV/HCV co-infection in Fujian Province, southeastern China.
    J Med Virol. 2016 Aug 23. doi: 10.1002/jmv.24666.
    >> Share

    July 2016
  66. DE PASCHALE M, Manco MT, Belvisi L, Cagnin D, et al
    Evaluation of LIAISON(R) XL system for HBsAg, and anti-HCV and anti-HIV/Ag p24.
    J Med Virol. 2016 Jul 28. doi: 10.1002/jmv.24648.
    >> Share

  67. VARMAZYAR S, Shoja Z, Kakavand-Ghalehnoei R, Shahmahmoodi S, et al
    Molecular typing of human herpesvirus 8 among HIV positive in comparison to HIV-negative individuals in Iran.
    J Med Virol. 2016 Jul 27. doi: 10.1002/jmv.24644.
    >> Share

  68. BAUDI I, Iijima S, Chin'ombe N, Mtapuri-Zinyowera S, et al
    Molecular epidemiology of co-infection with hepatitis B virus and human immunodeficiency virus (HIV) among adult patients in Harare, Zimbabwe.
    J Med Virol. 2016 Jul 26. doi: 10.1002/jmv.24641.
    >> Share

  69. OLESEN TB, Mwaiselage J, Iftner T, Kahesa C, et al
    Risk factors for genital Human Papillomavirus among men in Tanzania.
    J Med Virol. 2016 Jul 12. doi: 10.1002/jmv.24627.
    >> Share

  70. SADEGHI A, Shirvani-Dastgerdi E, Tacke F, Yagmur E, et al
    HBsAg mutations related to occult hepatitis B virus infection in HIV-positive patients result in a reduced secretion and conformational changes of HBsAg.
    J Med Virol. 2016 Jul 6. doi: 10.1002/jmv.24623.
    >> Share

    June 2016
  71. KAMORI D, Hasan Z, Ohashi J, Kawana-Tachikawa A, et al
    Identification of two unique naturally occurring Vpr sequence polymorphisms associated with clinical parameters in HIV-1 chronic infection.
    J Med Virol. 2016 Jun 22. doi: 10.1002/jmv.24612.
    >> Share

    Different HIV-1 env frames: gp120 and ASP (antisense protein) biosynthesis, and theirs co-variation tropic amino acid signatures in X4- and R5-viruses.
    J Med Virol. 2016 Jun 22. doi: 10.1002/jmv.24611.
    >> Share

  73. ARALAGUPPE SG, Winner D, Singh K, Sarafianos SG, et al
    Increased replication capacity following evolution of PYxE insertion in gag-p6 is associated with enhanced virulence in HIV-1 subtype C from East Africa.
    J Med Virol. 2016 Jun 22. doi: 10.1002/jmv.24610.
    >> Share

  74. BEGHIN JC, Ruelle J, Sokal E, Bachy A, et al
    Effectiveness of the South African expanded program of immunization against hepatitis B in children infected with human immunodeficiency virus-1 living in a resource-limited setting of Kwazulu-Natal.
    J Med Virol. 2016 Jun 13. doi: 10.1002/jmv.24598.
    >> Share

    May 2016
  75. ROSCA A, Anton G, Botezatu A, Temereanca A, et al
    miR-29a associates with viro-immunological markers of HIV infection in treatment experienced patients.
    J Med Virol. 2016 May 27. doi: 10.1002/jmv.24586.
    >> Share

  76. PERNAS B, Grandal M, Tabernilla A, Cid P, et al
    Long-term clinical experience with darunavir (2007-2015) in a large cohort of HIV-infected patients in Spain.
    J Med Virol. 2016 May 24. doi: 10.1002/jmv.24585.
    >> Share

  77. MICHELINI Z, Galluzzo CM, Pirillo MF, Francisci D, et al
    HIV-1 DNA dynamics and variations in HIV-1 DNA protease and reverse transcriptase sequences in multidrug-resistant patients during successful raltegravir-based therapy.
    J Med Virol. 2016 May 19. doi: 10.1002/jmv.24581.
    >> Share

  78. MOTA LD, Nishiya AS, Finger-Jardim F, Barral MF, et al
    Prevalence of human pegivirus (HPgV) infection in patients carrying HIV-1C or non-C in southern Brazil.
    J Med Virol. 2016 May 12. doi: 10.1002/jmv.24574.
    >> Share

  79. ALBERTI A, Lacoin L, Morais E, Lefevre C, et al
    A literature review of the distribution of hepatitis C virus genotypes across Europe.
    J Med Virol. 2016 May 12. doi: 10.1002/jmv.24573.
    >> Share

  80. ZHANG L, Tian Y, Wen Z, Zhang F, et al
    Asialoglycoprotein receptor facilitates infection of PLC/PRF/5 cells by HEV through interaction with ORF2.
    J Med Virol. 2016 May 7. doi: 10.1002/jmv.24570.
    >> Share

    April 2016
  81. LI L, Sun G, Zhong P, Han J, et al
    HIV-1 Thai B strain has spread out of former plasma donors into general population through sexual contact in Henan, China.
    J Med Virol. 2016;88:614-21.
    >> Share

    January 2016
  82. BOKHARAEI-SALIM F, Keyvani H, Esghaei M, Zare-Karizi S, et al
    Prevalence of occult hepatitis C virus infection in the Iranian patients with human immunodeficiency virus infection.
    J Med Virol. 2016 Jan 14. doi: 10.1002/jmv.24474.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016